Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion

被引：0
|
作者：
Songwang Cai
Zhiqiang Ye
Xiaohong Wang
Yuhang Pan
Yimin Weng
Sen Lao
Hongbo Wei
Lian Li
机构：
[1] Sun Yat-sen University,Department of Cardiothoracic Surgery, The Third Affiliated Hospital
[2] Sun Yat-sen University,Department of Emergency, The Third Affiliated Hospital
[3] Sun Yat-sen University,Department of Radiology, The Third Affiliated Hospital
[4] Sun Yat-sen University,Department of Pathylogy, The Third Affiliated Hospital
[5] Sun Yat-sen University,Department of Gastrointestinal Surgery, The Third Affiliated Hospital
[6] Sun Yat-sen (Zhongshan) University,State Key Laboratory of Biocontrol
来源：
Journal of Experimental & Clinical Cancer Research | / 34卷
关键词：
PAK4; LIM kinase 1; Non-small cell lung cancer; Migration; Invasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion
    Cai, Songwang
    Ye, Zhiqiang
    Wang, Xiaohong
    Pan, Yuhang
    Weng, Yimin
    Lao, Sen
    Wei, Hongbo
    Li, Lian
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [2] p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
    Siu, Michelle K. Y.
    Chan, Hoi Yan
    Kong, Daniel S. H.
    Wong, Esther S. Y.
    Wong, Oscar G. W.
    Ngan, Hextan Y. S.
    Tam, Kar Fai
    Zhang, Hongquan
    Li, Zhilun
    Chan, Queeny K. Y.
    Tsao, Sai Wah
    Stromblad, Staffan
    Cheung, Annie N. Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (43) : 18622 - 18627
  • [3] SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
    Li, Jing
    Zhao, Lifang
    Pan, Yunjian
    Ma, Xiao
    Liu, Li
    Wang, Wuzhang
    You, Wenjie
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (03) : 756 - 766
  • [4] Overexpression of KRT 17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
    Wang, Zhao
    Yang, Mai-Qing
    Lei, Lei
    Fei, Liang-Ru
    Zheng, Yi-Wen
    Huang, Wen-Jing
    Li, Zhi-Han
    Liu, Chen-Chen
    Xu, Hong-Tao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7485 - 7497
  • [5] p21-activated kinase 4 promotes proliferation, migration, and invasion of human gastric cancer cells
    Wang, Chong-Gao
    Wu, Zhao-Shu
    Han, Wei
    Jiang, Xiao-Yan
    Lu, Kai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5146 - 5153
  • [6] LYAR promotes the proliferation of non-small cell lung cancer and is associated with poor prognosis
    Lu, Xiao-Ning
    Ju, Guan-Jun
    Wang, Yu-Xin
    Wang, Yong-Liang
    Wang, Kun
    Chen, Jian-Le
    Cai, Wei
    Zang, Qi-Wei
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2021, 59 (04) : 282 - 290
  • [7] Overexpression of p21-activated kinase 1 promotes endometrial cancer progression
    Lu, Wen
    Qu, Jun-Jib
    Li, Bi-Lan
    Lu, Cong
    Yan, Qin
    Wu, Xiao-Mei
    Chen, Xiao-Yu
    Wan, Xiao-Ping
    ONCOLOGY REPORTS, 2013, 29 (04) : 1547 - 1555
  • [8] Overexpression of immunohistochemical RhoA associated with poor prognosis in operable non-small cell lung cancer
    Lou, Ming
    Gao, Zhao-Jia
    Zhu, Tao
    Mao, Xiao-Liang
    Yuan, Kai
    Tong, Ji-Chun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7577 - 7584
  • [9] Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
    Hong, Ling-Zhi
    Wei, Xiao-Wei
    Chen, Jin-Fei
    Shi, Yi
    ONCOLOGY LETTERS, 2013, 6 (06) : 1595 - 1603
  • [10] Overexpression of lncRNA EGFR-AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non-small cell lung cancer
    Xu, Yu-Hua
    Tu, Jian-Ren
    Zhao, Tian-Tian
    Xie, Shi-Guang
    Tang, Sheng-Bo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (01) : 295 - 305
12345